Publications (151,451)

Search

Transnationale Solidaritätskonflikte. Eine vergleichende Analyse verfassungsgerichtlicher Konfliktbearbeitung in der Eurokrise

Farahat A (2021)

Authored book, Monography

Heart failure in the young: Insights into myocardial recovery with ventricular assist device support

Delmo EMJ, Javier MFDM, Boethig D, Ruffer A, Cesnjevar R, Dandel M, Hetzer R (2021)

Journal article

The aetiologies of epilepsy

Balestrini S, Arzimanoglou A, Blümcke I, Scheffer IE, Wiebe S, Zelano J, Walker MC (2021)

Journal article

A critical appraisal of evidence-and consensus-based guidelines for actinic keratosis

Wessely A, Steeb T, Heppt F, Hornung A, Kaufmann M, Koch E, Toussaint F, et al. (2021)

Journal article

Möglichkeiten und Grenzen bei der Ermittlung von Wahrheit mit Maschinellem Lernen

Riess C (2021)

Book chapter / Article in edited volumes

Results from CONTESSA: A phase 3 study of tesetaxel plus a reduced dose of capecitabine versus capecitabine alone in patients with HER2-, hormone receptor plus (HR plus ) metastatic breast cancer (MBC) who have previously received a taxane

O'Shaughnessy J, Schwartzberg L, Piccart M, Rugo HS, Yardley DA, Cortes J, Untch M, et al. (2021)

Conference contribution

Treatment-related amenorrhea with T-DM1 plus pertuzumab (KP) is lower than with docetaxel/carboplatin/ trastuzumab/pertuzumab (TCHP) in the phase III neoadjuvant KRISTINE trial

Hurvitz SA, Fresco R, Afenjar K, Stroyakovskiy D, Huang CS, Wildiers H, Jung KH, et al. (2021)

Conference contribution

Ribecca - a phase 3b, multi-center, open label study for women with estrogen receptor positive, locally advanced or metastatic breast cancer treated with ribociclib (lee011) in combination with letrozole: Final results

Reinisch M, Nusch A, Decker T, Hartkopf A, Heinrich BJ, Kurbacher CM, Fuchs R, et al. (2021)

Conference contribution

High Ki-67 as a biomarker for identifying patients with high risk early breast cancer treated in monarchE

Harbeck N, Johnston S, Fasching P, Martin M, Toi M, Rastogi P, Song C, et al. (2021)

Conference contribution

Real-world efficacy of ribociclib plus aromatase inhibitor/fulvestrant, or endocrine monotherapy, or chemotherapy as first-line treatment in women with HR-positive, HER2-negative locally advanced or metastatic breast cancer: Third interim analysis from the RIBANNA study

Wockel A, Brucker C, Decker T, Falbrede J, Forstbauer H, Gohler T, Hoffmann O, et al. (2021)

Conference contribution

‹ 1 ... 3,571 3,572 3,573 3,574 3,575 ... 15,146 ›